Global Neglected Tropical Disease Market, By Disease (Dengue, Rabies, Trachoma, Buruli Ulcer, Yaws, Leprosy, Chagas Disease, Human African Trypanosomiasis, Leishmaniases, Soil-Transmitted Helminthiases, Others) Product (Drugs, Vaccines) – Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years factors including a lack of basic services such as clean water, a lack of proper hygiene maintenance, and a lack of steps to prevent such diseases, have contributed to an increase in the prevalence of neglected tropical diseases in recent years. In the coming years, this situation is expected to create significant sales opportunities for companies operating in the global neglected tropical disease market.
Data Bridge Market Research analyses that the neglected tropical disease market is expected to reach the value of USD 2.04 billion by the year 2029, at a CAGR of 5.75% during the forecast period. The growing number of programs aimed at combating NTDs is expected to open up new opportunities for the market.
Market Definition
Neglected tropical diseases (NTDs) are a diverse group of communicable diseases that occur in tropical and subtropical environments in 149 countries, affecting over one billion people and costing developing economies billions of dollars each year. NTDs such as dengue fever, lymphatic filariasis, Chagas, trachoma, and leishmaniasis are referred to as neglected because they primarily affect the poor and have historically received less attention than other diseases. NTDs thrive in developing regions of the world with poor water quality, sanitation, and access to healthcare.
Neglected Tropical Disease Market Dynamics
Drivers
- The rise in the NTD cases in tropical and subtropical countries
Increased government initiative, increased awareness about NTDs, and an increase in NTD cases in tropical and subtropical countries are expected to drive market growth during the forecast period. There is also an increase in cases of Buruli ulcers and dengue fever around the world, which will accelerate the growth of the neglected tropical disease market.
- Government intervention in rising awareness about neglected tropical diseases
Government organisations in major countries around the world are taking steps to raise awareness about neglected tropical diseases and increase the availability of medicines used to treat these diseases. An increase in the number of such initiatives is expected to boost growth prospects in the global neglected tropical disease market in the coming years.
- Regulatory Compliance
Maintaining compliance with medical reforms and regulations raises the demand for these solutions.
Opportunities
Major players in the global market for neglected tropical diseases are increasing their financial and time investments in R&D activities. This strategy is assisting them in the development of new and more effective drugs for the treatment of neglected tropical diseases.
This neglected tropical disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Neglected Tropical Disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- The World Health Organization (WHO) is attempting to raise awareness about one of the most underappreciated tropical diseases, Buruli ulcer. It has launched the Global Buruli Ulcer Initiative to raise awareness of the condition.
- The UN Development Programme (UNDP) and various organisations launched the Uniting Efforts for Innovation, Access, and Delivery initiative in January 2019 to improve access to medicines, diagnostics, and vaccines for neglected tropical diseases. Over the forecast period, many such initiatives are expected to increase the consumption of neglected tropical disease treatment drugs. Stop Dengue mission in India, which aims to reduce morbidity and mortality rates due to dengue in the country by raising awareness about better hygiene practises.
Global Neglected Tropical Disease Market Scope
The neglected tropical disease market is segmented on the basis of disease and product. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Dengue
- Rabies
- Trachoma
- Buruli Ulcer
- Yaws
- Leprosy
- Chagas Disease
- Human African Trypanosomiasis
- Leishmaniases
- Soil-Transmitted Helminthiases
- Others
On the basis of disease, the neglected tropical disease market is segmented into dengue, rabies, trachoma, buruli ulcer, yaws, leprosy, chagas disease, human african trypanosomiasis, leishmaniases, soil-transmitted helminthiases and others.
Product
- Drugs
- Vaccines
Based on product, the neglected tropical disease market is segmented into drugs and vaccines.
Neglected Tropical Disease Market Regional Analysis/Insights
The neglected tropical disease market is analysed and market size insights and trends are provided by country, disease and product as referenced above.
The countries covered in the neglected tropical disease market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is likely to maintain its lead. The primary factor influencing demand here is the increasing inflow of transient population from developed to developing countries. Furthermore, Europe will continue to be a significant player in the global neglected tropical disease treatment. However, it is expected that Asia Pacific will develop as a strategic region. Improving healthcare, government pressure to reduce NTDs, and increasing individual awareness will boost demand in this sector..
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The neglected tropical disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Neglected Tropical Disease market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Neglected Tropical Disease market. The data is available for historic period 2010-2020.
Competitive Landscape and Neglected Tropical Disease Market Share Analysis
The neglected tropical disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Neglected Tropical Disease market.
Some of the major players operating in the neglected tropical disease market are GlaxoSmithKline plc., Bayer AG, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences, Inc., Astellas Pharma Inc., Sanofi, Eisai Co., Ltd., Merck KGaA, among others.
SKU-
